SONOGLIO: Intraoperative Sonographically Guided Resection of Non-enhancing Gliomas

Sponsor
Sklifosovsky Institute of Emergency Care (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05470374
Collaborator
(none)
96
1
2
60
1.6

Study Details

Study Description

Brief Summary

The purpose of the study is to determine whether intraoperative ultrasound guided resection of glioma without contrast enhancement in magnetic resonance imaging can achieve higher extent of resection than surgery without intraoperative sonography

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intraoperative sonography
N/A

Detailed Description

Gliomas, not enhancing contrast agent in magnetic resonance imaging (MRI), are usually low-grade gliomas. They rarely show intraoperative fluorescence using 5-aminolevulinic acid or fluorescein. Intraoperative high-field MRI, sonography and navigation are the only ways to assess extent of their resection during surgery. MRI is the gold standard, but interrupts surgical workflow and only few hospitals are equipped with device like that. Navigation eventually looses it's precision due to brainshift. Ultrasound allows assess tumor remnants in real time but has worse imaging quality. Currently no randomized trials published their results about efficiency of intraoperative sonography in removing low-grade gliomas.

Objective of the study is to determine whether intraoperative ultrasound guided resection of non-enhancing gliomas can achieve higher extent of resection than surgery without intraoperative sonography.

Participants of the study will be randomly operated with and without intraoperative ultrasound. Extent of resection will be assessed in postoperative MRI by blinded radiologists.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
96 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Glioma extent of resection will be assessed by radiologists blinded for the treatment arm
Primary Purpose:
Treatment
Official Title:
Intraoperative Sonographically Guided Resection of Gliomas Not Enhancing Contrast Agent in Magnetic Resonance Imaging: a Randomised, Controlled Trial
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Aug 31, 2027
Anticipated Study Completion Date :
Aug 31, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ultrasound

Glioma resection with intraoperative sonography

Procedure: Intraoperative sonography
ultrasound scanning of brain to search tumor remnants

No Intervention: Non-ultrasound

Glioma resection without intraoperative sonography

Outcome Measures

Primary Outcome Measures

  1. Extent of resection in percents [within 48 hours after surgery]

    Extent of resection = (preoperative tumor volume - postoperative tumor volume) / preoperative tumor volume x 100

Secondary Outcome Measures

  1. Gross total resection (Yes or No) [within 48 hours after surgery]

    Gross total resection is a total removal of tumor (or 100 percents extent of resection)

  2. Neurological deterioration after surgery (improving, stable, deterioration) [within 10 days after surgery]

    Assesses dynamics of motor, speech, visual and cognitive functions before and after surgery

  3. Karnofsky Performance status in percents [within 10 days after surgery]

    Assesses patients' possibilities to self-service

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • single supratentorial gliomas without contrast enhancement in preoperative magnetic resonance imaging (presumed low-grade gliomas)

  • newly diagnosed

  • previously untreated

  • Karnofsky Performance Status 60-100%

  • age 18-79 years

  • performed magnetic resonance imaging with contrast enhancement

Exclusion Criteria:
  • glioma spreading to basal ganglia or brainstem

  • previously performed radiotherapy, chemotherapy or immunotherapy

  • planned supratotal tumor resection until neurophysiologically revealed eloquent areas

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sklifosovsky Institute of Emergency Care Moscow Russian Federation 129090

Sponsors and Collaborators

  • Sklifosovsky Institute of Emergency Care

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alexander Dmitriev, Neurosurgeon, MD, Sklifosovsky Institute of Emergency Care
ClinicalTrials.gov Identifier:
NCT05470374
Other Study ID Numbers:
  • 9
First Posted:
Jul 22, 2022
Last Update Posted:
Jul 22, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2022